
Beam Therapeutics crafts CRISPR-based genetic medicines for precise, potentially lifelong disease treatments.
Beam Therapeutics is seeking a Senior Director, Market Access Strategy to drive market access strategy for key BEAM assets, focusing on BEAM-101. The successful candidate will create and develop tactics and market access deliverables for all payer types, as well as IDN / health systems, to support the launch of BEAM products.
Beam Therapeutics crafts CRISPR-based genetic medicines for precise, potentially lifelong disease treatments.